HEALTH X PLATFORM
|
|
| BOM : 533259     NSE : HEALTHX     | |
| LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Good [Stock is Cheap] Debt : Low |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
Nov 20,2026 |
|
Price(EOD): ₹ 274.00
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Finance - NBFC |
| MCap: ₹ 871.32 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| HEALTH X PLATFORM | -1.7% | -2.3% | -8.9% |
| BAJAJ FINANCE | 0.9% | 19.2% | 6.5% |
| SHRIRAM FINANCE | -0.5% | 8.2% | 19.4% |
| JIO FINANCIAL SERVICES | -0.5% | 6.7% | -27.4% |
| MUTHOOT FINANCE | -8% | 5.6% | -30.5% |
| CHOLAMANDALAM INVESTMENT AND FINANCE COMPANY | 1.9% | 22.3% | 10.4% |
| TATA CAPITAL | -1.6% | 12.2% | 6.2% |
| BAJAJ HOLDINGS & INVESTMENT | 3.1% | 3.8% | -6.7% |
| ADITYA BIRLA CAPITAL | 3.7% | 18.6% | 24.5% |
FUNDAMENTAL ANALYSIS OF HEALTH X PLATFORM
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF HEALTH X PLATFORM
 | Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
-37.34
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -23.34 Cr
[Latest Qtr - Sep2026 - Consolidated Results ] 1.36
P/B Calculated based on Book Value of Rs 640.89 Cr
[Latest Year - Mar2026 - Consolidated Results ] 0.53
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,650.45 Cr
[Latest Qtr - Sep2026 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
NA -38% -39% |
SHARE PRICE MOMENTUM OF HEALTH X PLATFORM
HEALTH X PLATFORM vs SENSEX
DEBT OF HEALTH X PLATFORM
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2026 2025 2024 Avg_3yrs |
0 0 0 - |
0.03 0 0 0.01 |
|
[Last Annual Data : Mar2026]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF HEALTH X PLATFORM
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Sep2026 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF HEALTH X PLATFORM
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
8.33% -165.64% -871.6% -740.51% |
60.65% 1.66% 18.23% 17.57% |
| QtrlyTrend |
2 | |
| Latest Qtr: Sep2026 | ||
| Quarterly Result Analysis → | ||
HEALTH X PLATFORM related INDICES
You may also like the below Video Courses
FAQ about HEALTH X PLATFORM
Is HEALTH X PLATFORM good for long term investment?
As on Nov 20,2026, the Fundamentals of HEALTH X PLATFORM look Poor and hence it may not be good for long term investment ! See Financial Performance of HEALTH X PLATFORM . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is HEALTH X PLATFORM UnderValued or OverValued?
As on Nov 20,2026, HEALTH X PLATFORM is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of HEALTH X PLATFORM ?
As on Nov 20,2026, the Intrinsic Value of HEALTH X PLATFORM is Rs. 446.68 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -3,219.65
Fair Value [Median EV / Sales Model] : Rs. 442.92
Fair Value [Median Price / Sales Model] : Rs. 450.44
Estimated Median Fair Value of HEALTH X PLATFORM : Rs. 446.68
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.